Practical Application Of Recent Evidence On Disease-Modifying Therapies For Sma

Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA

Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion

Touch Medical Media

Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion

Touch Medical Media

Authorized Disease Modifying Treatments for SMA | The SMA Victor

Disease Modifying Therapies | Spinal Muscular Atrophy 2023

Helping Patients With SMA Understand Diagnosis and Treatment in a New Era of Therapy

Evidence-Based Strategies to Facilitate Access to Therapies for Patients with SMA

“Disease Modifying Therapies in Spinal Muscular Atrophy” by Amanda Rogers,MD

University of Louisville Child Neurology Residency

Disease Modifying Therapies in Spinal Muscular Atrophy by Dr Amanda Rogers

Mary Schroth, MD: Making Strides In Treating Spinal Muscular Atrophy

Adopting Neuromuscular Therapies for SMA

Using real-world data in SMA management

Evidence-Based Strategies to Improve Access to Therapies for Patients with Spinal Muscular Atrophy

An Update on Spinal Muscular Atrophy Current Treatment Paradigms and Ongoing Research

MDA

Update in SMA Research and Clinical Trials

MDA

Spinal Muscular Atrophy: Navigating Recent Therapeutic Advances

New England CEPAC: Evidence Presentation, Spinal Muscular Atrophy

Institute for Clinical and Economic Review (ICER)

Best Practices in the Care of Adult Patients With Spinal Muscular Atrophy

Cure SMA and Biohaven Pharmaceuticals Clinical Trial Update Webinar

An update on Progress with the SMA Treatment Programmes in the UK

Spinal Muscular Atrophy UK